Nicofuranose: Difference between revisions
No edit summary |
No edit summary |
||
Line 26: | Line 26: | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
Latest revision as of 17:11, 27 July 2014
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C30H24N4O10 |
Molar mass | 600.533 g/mol |
WikiDoc Resources for Nicofuranose |
Articles |
---|
Most recent articles on Nicofuranose Most cited articles on Nicofuranose |
Media |
Powerpoint slides on Nicofuranose |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Nicofuranose at Clinical Trials.gov Clinical Trials on Nicofuranose at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Nicofuranose
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Nicofuranose Discussion groups on Nicofuranose Patient Handouts on Nicofuranose Directions to Hospitals Treating Nicofuranose Risk calculators and risk factors for Nicofuranose
|
Healthcare Provider Resources |
Causes & Risk Factors for Nicofuranose |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Nicofuranose is a niacin derivative used as a hypolipidemic agent.
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Nicotinates